Call for Abstracts
Call for Abstracts
Submission Period
October 14 (Tue), 2025 – Noon, January 9 (Fri), 2026 (JST)
*We will start accepting abstract submissions for symposiums, panel discussions, etc. from around this November. Details will be announced on this page later.
Qualification
If author and co-authors for this registration belong to overseas affiliations, they are not required to be a member of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT). However, if the author/co-author belongs to an institution in Japan, membership registration to CVIT by the meeting dates is required.
Contact for CVIT membership
The Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)
- E-mail：info@cvit.jp
- CVIT website (Japanese only)：http://www.cvit.jp/
Presentation Method and Categories
Presentation Method
Please choose from the below items.
The presentation method will be finalized by the President and might be different from your request. Thank you for your understanding.
We are planning "Nightmare Case Special Session" to widely share experiences in treating and managing difficult-to-treat complex cases and complications, so we encourage applications (limited to educational applications). All catheter-related procedures, including PCI, EVT, and SHD Interventions, are eligible.
| 1 | Research Presentation |
|---|---|
| 2 | Nightmare Case (PCI, EVT, SHD) |
| 3 | Case Report |
Category for Free Paper
| 1 | Access site |
|---|---|
| 2 | ACS |
| 3 | Antithrombotic therapy |
| 4 | Aortic valve intervention (TAVI/BAV) |
| 5 | CABG |
| 6 | Calcified lesion |
| 7 | Cardiomyopathy |
| 8 | Cardiovascular risk factors |
| 9 | CKD/HD |
| 10 | Closure device (PFO, ASD, LAAO, PDA) |
| 11 | CLTI |
| 12 | Complex PCI/complex lesions |
| 13 | Complications |
| 14 | Congenital heart disease |
| 15 | Coronary physiology |
| 16 | Coronary vasospasm/CMD/INOCA |
| 17 | CTO |
| 18 | Economy/cost |
| 19 | Emergency care/cardiogenic shock |
| 20 | Epidemiology |
| 21 | EVT (LEAD) |
| 22 | EVT (other than LEAD) |
|---|---|
| 23 | Heart failure |
| 24 | Hemostasis |
| 25 | ICD/CRT/PM/Electrophysiology |
| 26 | Intracoronary imaging |
| 27 | Mechanical circulatory support |
| 28 | Mitral valve intervention |
| 29 | Non-invasive testing |
| 30 | Pathology |
| 31 | PCI devices |
| 32 | Peripheral artery disease |
| 33 | PTSMA (alcohol septal ablation) |
| 34 | Pulmonary embolism/DVT/venouse disease |
| 35 | Pulmonary hypertension/BPA |
| 36 | Radiation exposure |
| 37 | Renal denavation |
| 38 | Restenosis/stent (scaffold) thrombosis |
| 39 | Secondary prevention/medical treatment |
| 40 | Takotsubo syndrome |
| 41 | Tricuspid valve intervention |
| 42 | Others |
Session information of Symposium
We will start accepting abstract submissions for symposiums, panel discussions, etc. from around this November. Details will be announced on this page later.
Abstract Submission Guidelines
Please fill out the application form and submit it via e-mail.
Please read the following guidelines carefully before the submission.
Please note that the word limit for the abstract has changed.
| Language | English |
|---|---|
| Word Limit | Title: Up to 20 words Abstract Body: 250 words (200 words with a chart/image) |
| Chart/Image | You can upload one file in "jpg", "png" or "gif" format. |
Abstract Submission Guidelines
Please fill out the application form and submit it via e-mail.
Please read the following guidelines carefully before the submission.
Notification of Acceptance/Rejection
The results will be notified by e-mail in the beginning of March, 2026.
Please note that presentation method will be finalized by the reviewers of the abstracts and might be different from your request.
Application Form
Contact for Abstract Submission
CVIT2026 Administration Office
-
E-mail：cvit2026@c-linkage.co.jp
TEL: +81-3-3263-8688
Late Breaking Clinical Trial
Submission Period
October 14 (Tue), 2025 – Noon, February 27 (Fri), 2026 (JST)
Abstract Submission Guidelines
Please fill out the application form and submit it via e-mail. Please read the following guidelines carefully before the submission.
Notification of Acceptance/Rejection
The results will be notified by e-mail in the beginning of March, 2026.
Please note that presentation method will be finalized by the reviewers of the abstracts and might be different from your request.
Application Form
Contact for Abstract Submission
CVIT2026 Administration Office
-
E-mail：cvit2026@c-linkage.co.jp
TEL: +81-3-3263-8688